by Rachad Davis
April 21, 2016
Dana has been with ORC for 15 years helping clients adapt to a changing healthcare landscape. She specializes in the design of research methodologies to inform product and program development and strategy. Prior to joining ORC, she worked for GlaxoSmithKline in its Immunology division supporting in-licensing development, and prior to that she worked at Roche and conducted research on CD43 as a regulator of T-lymphocyte trafficking at a Tufts-New England Medical Center Department of Pathology laboratory. Dana has a B.S. in Biochemistry and Molecular Biology from Pennsylvania State University.